Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors

[1]  F. Guyon,et al.  Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions , 2015, Modern Pathology.

[2]  D. N. Markowski,et al.  Cytogenetically normal uterine leiomyomas without MED12-mutations – a source to identify unknown mechanisms of the development of uterine smooth muscle tumors , 2014, Molecular Cytogenetics.

[3]  Haiyang Guo,et al.  Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma , 2014, Cancer.

[4]  E. Oliva,et al.  Uterine Leiomyomas With Bizarre Nuclei: A Clinicopathologic Study of 59 Cases , 2014, The American journal of surgical pathology.

[5]  S. Croce,et al.  Intracystic papillary carcinoma of the breast: a diagnostic challenge with major clinical impact. , 2014, Anticancer research.

[6]  L. Aaltonen,et al.  Genomics of uterine leiomyomas: insights from high-throughput sequencing. , 2014, Fertility and sterility.

[7]  Jian-jun Wei,et al.  MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma , 2014, Modern Pathology.

[8]  R. Kurman,et al.  WHO classification of tumours of female reproductive organs , 2014 .

[9]  L. Aaltonen,et al.  Chromothripsis in uterine leiomyomas. , 2013, The New England journal of medicine.

[10]  L. Aaltonen,et al.  Characterization of uterine leiomyomas by whole-genome sequencing. , 2013, The New England journal of medicine.

[11]  J. Fletcher,et al.  MED12 mutations in leiomyosarcoma and extrauterine leiomyoma , 2013, Modern Pathology.

[12]  K. Hunt,et al.  Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience , 2013, Annals of Surgical Oncology.

[13]  F. Moinfar,et al.  Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases , 2012, BMC Genomics.

[14]  Christopher C. Holmes,et al.  GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples , 2012, Bioinform..

[15]  F. Chibon,et al.  MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors , 2012, PloS one.

[16]  L. Aaltonen,et al.  MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas , 2011, Science.

[17]  J. Dermody,et al.  Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas , 2009, Modern Pathology.

[18]  P. Clement,et al.  Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP):: A Clinicopathologic Analysis of 16 Cases , 2009, The American journal of surgical pathology.

[19]  K. Hunt,et al.  Genetic aberrations in soft tissue leiomyosarcoma. , 2009, Cancer letters.

[20]  P. Pandolfi,et al.  The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas , 2007, Nature Medicine.

[21]  J. Fletcher,et al.  Distinctive Cytogenetic Profile in Benign Metastasizing Leiomyoma: Pathogenetic Implications , 2007, The American journal of surgical pathology.

[22]  C. Toon,et al.  Myxoid symplastic leiomyoma of the uterus. , 2006, Pathology.

[23]  P. Cin,et al.  Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features , 2006, Genes, chromosomes & cancer.

[24]  P. Nederlof,et al.  A multiplex PCR predictor for aCGH success of FFPE samples , 2005, British Journal of Cancer.

[25]  U. Surti,et al.  Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. , 2005, Cancer genetics and cytogenetics.

[26]  C. Walker,et al.  Uterine Fibroids: The Elephant in the Room , 2005, Science.

[27]  Shuanzeng Wei,et al.  Uterine adenomyoma with lymphoid infiltration simulating lymphoma. , 2004, Gynecologic oncology.

[28]  P. Cin,et al.  Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling , 2004, Genes, chromosomes & cancer.

[29]  M. Zhan,et al.  Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. , 2004, Gynecologic oncology.

[30]  Kuan-Hui Huang,et al.  Multiple uterine angioleiomyomas in a woman presenting with severe menorrhagia. , 2003, Gynecologic oncology.

[31]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[32]  E. Harlow,et al.  The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.

[33]  C. Morton,et al.  Leiomyomata: heritability and cytogenetic studies. , 2001, Human reproduction update.

[34]  A. Kaider,et al.  Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. , 1999, Gynecologic oncology.

[35]  B. Quade,et al.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. , 1999, The American journal of pathology.

[36]  C. Villena-Heinsen,et al.  Leiomyosarcomas of the female genital tract: a clinical and histopathological study. , 1998, European journal of gynaecological oncology.

[37]  B. Helpap,et al.  [Uterine leiomyosarcoma with subsequent pregnancy]. , 1998, Zentralblatt fur Gynakologie.

[38]  A. Berchuck,et al.  Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization , 1997, Molecular carcinogenesis.

[39]  S. Thoresen,et al.  Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. , 1997, European journal of cancer.

[40]  M. Shintaku Iipoleiomyomatous tumors of the uterus: A heterogeneous group? Histopathological study of five cases , 1996, Pathology international.

[41]  R. Prayson,et al.  Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. , 1996, The American journal of surgical pathology.

[42]  P. Clement,et al.  Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. , 1995, The American journal of surgical pathology.

[43]  J. Sklar,et al.  Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata , 1994, Genes, chromosomes & cancer.

[44]  R. Kempson,et al.  Problematic Uterine Smooth Muscle Neoplasms: A Clinicopathologic Study of 213 Cases , 1994, The American journal of surgical pathology.

[45]  A. Sandberg,et al.  Chromosomal abnormalities in leiomyosarcomas. , 1993, The American journal of pathology.

[46]  P. Clement,et al.  Diffuse, Perinodular, and Other Patterns of Hydropic Degeneration Within and Adjacent to Uterine Leiomyomas: Problems in Differential Diagnosis , 1992, The American journal of surgical pathology.

[47]  J. Fletcher,et al.  Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. , 1990, Cancer research.

[48]  N. Harris,et al.  Uterine Leiomyomas with Lymphoid Infiltration Simulating Lymphoma. A Report of Seven Cases , 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[49]  N. Weiss,et al.  The epidemiology of sarcomas of the uterus. , 1986, Journal of the National Cancer Institute.

[50]  J. Myles,et al.  Apoplectic leiomyomas of the uterus: A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage , 1985, The American journal of surgical pathology.

[51]  S. Gisser,et al.  Neurilemoma-like uterine myomas: an ultrastructural reaffirmation of their non-Schwannian nature. , 1977, American journal of obstetrics and gynecology.

[52]  R. Kurman,et al.  Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear‐cell leiomyoma. A clinical and pathologic analysis of 26 cases , 1976, Cancer.